A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation

William C. Kreisl, Kimberly J. Jenko, Christina S. Hines, Chul Hyoung Lyoo, Winston Corona, Cheryl L. Morse, Sami S. Zoghbi, Thomas Hyde, Joel E. Kleinman, Victor W. Pike, Francis J. McMahon, Robert B. Innis

Research output: Contribution to journalArticle

136 Citations (Scopus)

Abstract

Second-generation radioligands for translocator protein (TSPO), an inflammation marker, are confounded by the codominant rs6971 polymorphism that affects binding affinity. The resulting three groups are homozygous for high-affinity state (HH), homozygous for low-affinity state (LL), or heterozygous (HL). We tested if in vitro binding to leukocytes distinguished TSPO genotypes and if genotype could affect clinical studies using the TSPO radioligand [11 C]PBR28. In vitro binding to leukocytes and [ 11 C]PBR28 brain imaging were performed in 27 human subjects with known TSPO genotype. Specific [3 H]PBR28 binding was measured in prefrontal cortex of 45 schizophrenia patients and 47 controls. Leukocyte binding to PBR28 predicted genotype in all subjects. Brain uptake was ∼40% higher in HH than HL subjects. Specific [3 H]PBR28 binding in LL controls was negligible, while HH controls had ∼80% higher binding than HL controls. After excluding LL subjects, specific binding was 16% greater in schizophrenia patients than controls. This difference was insignificant by itself (P=0.085), but was significant after correcting for TSPO genotype (P=0.011). Our results show that TSPO genotype influences PBR28 binding in vitro and in vivo. Correcting for this genotype increased statistical power in our postmortem study and is recommended for in vivo positron emission tomography studies.

Original languageEnglish
Pages (from-to)53-58
Number of pages6
JournalJournal of Cerebral Blood Flow and Metabolism
Volume33
Issue number1
DOIs
Publication statusPublished - 2013 Jan 1

Fingerprint

Genetic Polymorphisms
Biomarkers
Genotype
Brain
Proteins
Leukocytes
Schizophrenia
In Vitro Techniques
Prefrontal Cortex
Neuroimaging
Positron-Emission Tomography
Inflammation

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Kreisl, William C. ; Jenko, Kimberly J. ; Hines, Christina S. ; Hyoung Lyoo, Chul ; Corona, Winston ; Morse, Cheryl L. ; Zoghbi, Sami S. ; Hyde, Thomas ; Kleinman, Joel E. ; Pike, Victor W. ; McMahon, Francis J. ; Innis, Robert B. / A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. In: Journal of Cerebral Blood Flow and Metabolism. 2013 ; Vol. 33, No. 1. pp. 53-58.
@article{5a8d4b706d1140618400df71036ea8a4,
title = "A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation",
abstract = "Second-generation radioligands for translocator protein (TSPO), an inflammation marker, are confounded by the codominant rs6971 polymorphism that affects binding affinity. The resulting three groups are homozygous for high-affinity state (HH), homozygous for low-affinity state (LL), or heterozygous (HL). We tested if in vitro binding to leukocytes distinguished TSPO genotypes and if genotype could affect clinical studies using the TSPO radioligand [11 C]PBR28. In vitro binding to leukocytes and [ 11 C]PBR28 brain imaging were performed in 27 human subjects with known TSPO genotype. Specific [3 H]PBR28 binding was measured in prefrontal cortex of 45 schizophrenia patients and 47 controls. Leukocyte binding to PBR28 predicted genotype in all subjects. Brain uptake was ∼40{\%} higher in HH than HL subjects. Specific [3 H]PBR28 binding in LL controls was negligible, while HH controls had ∼80{\%} higher binding than HL controls. After excluding LL subjects, specific binding was 16{\%} greater in schizophrenia patients than controls. This difference was insignificant by itself (P=0.085), but was significant after correcting for TSPO genotype (P=0.011). Our results show that TSPO genotype influences PBR28 binding in vitro and in vivo. Correcting for this genotype increased statistical power in our postmortem study and is recommended for in vivo positron emission tomography studies.",
author = "Kreisl, {William C.} and Jenko, {Kimberly J.} and Hines, {Christina S.} and {Hyoung Lyoo}, Chul and Winston Corona and Morse, {Cheryl L.} and Zoghbi, {Sami S.} and Thomas Hyde and Kleinman, {Joel E.} and Pike, {Victor W.} and McMahon, {Francis J.} and Innis, {Robert B.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1038/jcbfm.2012.131",
language = "English",
volume = "33",
pages = "53--58",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "1",

}

A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. / Kreisl, William C.; Jenko, Kimberly J.; Hines, Christina S.; Hyoung Lyoo, Chul; Corona, Winston; Morse, Cheryl L.; Zoghbi, Sami S.; Hyde, Thomas; Kleinman, Joel E.; Pike, Victor W.; McMahon, Francis J.; Innis, Robert B.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 33, No. 1, 01.01.2013, p. 53-58.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation

AU - Kreisl, William C.

AU - Jenko, Kimberly J.

AU - Hines, Christina S.

AU - Hyoung Lyoo, Chul

AU - Corona, Winston

AU - Morse, Cheryl L.

AU - Zoghbi, Sami S.

AU - Hyde, Thomas

AU - Kleinman, Joel E.

AU - Pike, Victor W.

AU - McMahon, Francis J.

AU - Innis, Robert B.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Second-generation radioligands for translocator protein (TSPO), an inflammation marker, are confounded by the codominant rs6971 polymorphism that affects binding affinity. The resulting three groups are homozygous for high-affinity state (HH), homozygous for low-affinity state (LL), or heterozygous (HL). We tested if in vitro binding to leukocytes distinguished TSPO genotypes and if genotype could affect clinical studies using the TSPO radioligand [11 C]PBR28. In vitro binding to leukocytes and [ 11 C]PBR28 brain imaging were performed in 27 human subjects with known TSPO genotype. Specific [3 H]PBR28 binding was measured in prefrontal cortex of 45 schizophrenia patients and 47 controls. Leukocyte binding to PBR28 predicted genotype in all subjects. Brain uptake was ∼40% higher in HH than HL subjects. Specific [3 H]PBR28 binding in LL controls was negligible, while HH controls had ∼80% higher binding than HL controls. After excluding LL subjects, specific binding was 16% greater in schizophrenia patients than controls. This difference was insignificant by itself (P=0.085), but was significant after correcting for TSPO genotype (P=0.011). Our results show that TSPO genotype influences PBR28 binding in vitro and in vivo. Correcting for this genotype increased statistical power in our postmortem study and is recommended for in vivo positron emission tomography studies.

AB - Second-generation radioligands for translocator protein (TSPO), an inflammation marker, are confounded by the codominant rs6971 polymorphism that affects binding affinity. The resulting three groups are homozygous for high-affinity state (HH), homozygous for low-affinity state (LL), or heterozygous (HL). We tested if in vitro binding to leukocytes distinguished TSPO genotypes and if genotype could affect clinical studies using the TSPO radioligand [11 C]PBR28. In vitro binding to leukocytes and [ 11 C]PBR28 brain imaging were performed in 27 human subjects with known TSPO genotype. Specific [3 H]PBR28 binding was measured in prefrontal cortex of 45 schizophrenia patients and 47 controls. Leukocyte binding to PBR28 predicted genotype in all subjects. Brain uptake was ∼40% higher in HH than HL subjects. Specific [3 H]PBR28 binding in LL controls was negligible, while HH controls had ∼80% higher binding than HL controls. After excluding LL subjects, specific binding was 16% greater in schizophrenia patients than controls. This difference was insignificant by itself (P=0.085), but was significant after correcting for TSPO genotype (P=0.011). Our results show that TSPO genotype influences PBR28 binding in vitro and in vivo. Correcting for this genotype increased statistical power in our postmortem study and is recommended for in vivo positron emission tomography studies.

UR - http://www.scopus.com/inward/record.url?scp=84871920442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871920442&partnerID=8YFLogxK

U2 - 10.1038/jcbfm.2012.131

DO - 10.1038/jcbfm.2012.131

M3 - Article

C2 - 22968319

AN - SCOPUS:84871920442

VL - 33

SP - 53

EP - 58

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 1

ER -